Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BED for Stem Cell Mobilization
NCT01110135Phase 2Completed
- Sponsor
- University of Washington
- Start
- Aug 2010
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bendamustine in lymphoma and multiple myeloma (MM), sponsored by University of Washington. Primary endpoint: Successful Mobilization and Collection of PBSCs at 1 week. Started Aug 2010; status: completed.
02
Drugs
bendamustine
03
Conditions
lymphomamultiple myeloma (MM)
Beyond the preview
Go deeper on NCT01110135.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01110135.